New modified -human chorionic gonadotropin proteins; HCG protein engineering and expression in a mammal or microorganism cell, for use as a contraceptive and antitumor recombinant vaccine, or a nucleic acid vaccine

Author： Roitt I.   Delves P.  

Publisher： Elsevier

ISSN： 0264-410X

Source： Vaccine, Vol.15, Iss.8, 1997-06, pp. : 935-935

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Combined antigent containing parts of three human cytomegalo virus proteins: fusion protein engineering for use as a recombinant vaccine

By  

Vaccine, Vol. 16, Iss. 6, 1998-04 ,pp. : 653-653

Elsevier

Access to resources Recommend Favorite

P-fimbriae of Escherichia coli as carriers for gonadotropin releasing hormone: development of a recombinant contraceptive vaccine

By van der Zee A.   Noordegraaf C.V.   van den Bosch H.   Gielen J.   Bergmans H.   Hoekstra W.   van Die I.  

Vaccine, Vol. 13, Iss. 8, 1995-06 ,pp. : 753-758

Elsevier

Access to resources Recommend Favorite

New isolated human cytomegalovirus DNA; expressing a recombinant protein and useful as a recombinant vaccine; potential diagnosis, prevention and therapy of human cytomegalovirus disease

By  

Vaccine, Vol. 15, Iss. 3, 1997-02 ,pp. : 340-340

Elsevier

Access to resources Recommend Favorite

Recombinant, octavalent group A streptococcal M protein vaccine

By Dale J.B.   Simmons M.   Chiang E.C.   Chiang E.Y.  

Vaccine, Vol. 14, Iss. 10, 1996-07 ,pp. : 944-948

Elsevier

Access to resources Recommend Favorite

Mucosal binding compositions for generating mucosal immune response; Chlamydia, HIV virus, hepatitis B virus or enterotoxigenic Escherichia coli antigen and cholera toxin binding subunit fusion protein expression, for use as a recombinant vaccine

By Lebens M.   Holmgren J.  

Vaccine, Vol. 14, Iss. 13, 1996-09 ,pp. : 1299-1299

Elsevier

Access to resources Recommend Favorite